Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004214712 | SCV003712423 | uncertain significance | not specified | 2021-10-22 | criteria provided, single submitter | clinical testing | The c.496C>G (p.L166V) alteration is located in exon 2 (coding exon 1) of the ZFHX2 gene. This alteration results from a C to G substitution at nucleotide position 496, causing the leucine (L) at amino acid position 166 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003918986 | SCV004730748 | likely benign | ZFHX2-related disorder | 2019-06-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |